Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Endocrinology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location

Diabetes Mellitus, Type 2 Clinical Trials

A listing of Diabetes Mellitus, Type 2 medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (497) clinical trials

A multicenter, Randomized, Double-Blind, Placebo-controlled Study to determine the efficacy and safety of Alogliptin Plus Metformin, Alogliptin alone, or Metformin alone in subjects with Type 2 Diabetes Please contact us for eligibility criteria.

Phase N/A

A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapaglifozin in Subjects with Type 2 Diabetes with Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB). Please contact us for eligibility criteria.

Phase

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of xxxxxxxxx in Subjects with Type 2 Diabetes with Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB) Patient Inclusion Criteria: Subjects must be willing and able to give ...

Phase

Dr. Carlos Bernal-Mizrachi is conducting a study to determine whether vitamin D supplementation in diabetic African-Americans with low vitamin D levels will reduce the progression of vascular disease. This study will take about 13 months to complete. There will be about 8 outpatient study visits (about 1 – 3 hours ...

Phase

If you are a man or woman over the age of 18, you may be eligible to participate in a clinical research study evaluating the safety and effectiveness of an investigational form of insulin to reduce blood sugar levels in individuals with Type 2 Diabetes. There is no cost to ...

Phase N/A

Metabolic Research Institute may have a new path for you to take. To learn more about this study or to see if you qualify to participate, please call: 561-802-3060 You may qualify for an exciting clinical trial. www.metabolic-institute.com/information.htm.

Phase N/A

The purpose of this study is to determine if lowering blood fat levels improves heart muscle function in people with type 2 diabetes. Participation will take about 13 weeks. There will be a total of 4 outpatient visits lasting 2 – 3 hours each. There will be blood tests, questionnaires, ...

Phase

Dapagliflozin Effect on Cardiovascular Events A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effect of Dapagliflozin 10 mg Once Daily on the Incidence of Cardiovascular Death, Myocardial Infarction or Ischemic Stroke in Patients With Type 2 Diabetes Inclusion Criteria: Provision of informed consent prior to any study specific procedures ...

Phase

To see if you may be eligible to participate in an OMNEON Clinical Research Program, you will be asked to answer some questions about your health history and current conditions. The information you provide will be kept confidential and will not be shared without your permission or except as required ...

Phase N/A

The primary efficacy objective is to determine whether treatment with dapagliflozin compared with placebo when added to current background therapy will result in a reduction in the incidence of the composite endpoint of cardiovascular death, myocardial infarction (MI), or ischemic stroke in patients with type 2 diabetes mellitus (T2DM) with ...

Phase